XOMA Corporation is a biotechnology royalty aggregator playing a unique role in helping biotech companies to improve human health. The Company focuses on acquiring economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates in return the seller receives non-dilutive and non-recourse funding to advance their internal drug candidates.